These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30647132)

  • 41. Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.
    Papillon JPN; Nakajima K; Adair CD; Hempel J; Jouk AO; Karki RG; Mathieu S; Möbitz H; Ntaganda R; Smith T; Visser M; Hill SE; Hurtado FK; Chenail G; Bhang HC; Bric A; Xiang K; Bushold G; Gilbert T; Vattay A; Dooley J; Costa EA; Park I; Li A; Farley D; Lounkine E; Yue QK; Xie X; Zhu X; Kulathila R; King D; Hu T; Vulic K; Cantwell J; Luu C; Jagani Z
    J Med Chem; 2018 Nov; 61(22):10155-10172. PubMed ID: 30339381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA-binding properties of the recombinant high-mobility-group-like AT-hook-containing region from human BRG1 protein.
    Singh M; D'Silva L; Holak TA
    Biol Chem; 2006; 387(10-11):1469-78. PubMed ID: 17081121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ATPase BRG1/SMARCA4 is a protein interaction platform that recruits BAF subunits and the transcriptional repressor REST/NRSF in neural progenitor cells.
    Jayaprakash S; Drakulic S; Zhao Z; Sander B; Golas MM
    Mol Cell Biochem; 2019 Nov; 461(1-2):171-182. PubMed ID: 31428904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells.
    Wu Q; Sharma S; Cui H; LeBlanc SE; Zhang H; Muthuswami R; Nickerson JA; Imbalzano AN
    Oncotarget; 2016 May; 7(19):27158-75. PubMed ID: 27029062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.
    Wu S; Ge Y; Huang L; Liu H; Xue Y; Zhao Y
    Cell Cycle; 2014; 13(18):2869-78. PubMed ID: 25486475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A PARP1-BRG1-SIRT1 axis promotes HR repair by reducing nucleosome density at DNA damage sites.
    Chen Y; Zhang H; Xu Z; Tang H; Geng A; Cai B; Su T; Shi J; Jiang C; Tian X; Seluanov A; Huang J; Wan X; Jiang Y; Gorbunova V; Mao Z
    Nucleic Acids Res; 2019 Sep; 47(16):8563-8580. PubMed ID: 31291457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brg1 Controls the Expression of Pax7 to Promote Viability and Proliferation of Mouse Primary Myoblasts.
    Padilla-Benavides T; Nasipak BT; Imbalzano AN
    J Cell Physiol; 2015 Dec; 230(12):2990-7. PubMed ID: 26036967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Catalytic activity of the proteasome fine-tunes Brg1-mediated chromatin remodeling to regulate the expression of inflammatory genes.
    Cullen SJ; Ponnappan S; Ponnappan U
    Mol Immunol; 2009 Dec; 47(2-3):600-5. PubMed ID: 19800126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HMGN proteins act in opposition to ATP-dependent chromatin remodeling factors to restrict nucleosome mobility.
    Rattner BP; Yusufzai T; Kadonaga JT
    Mol Cell; 2009 Jun; 34(5):620-6. PubMed ID: 19524541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits.
    Phelan ML; Sif S; Narlikar GJ; Kingston RE
    Mol Cell; 1999 Feb; 3(2):247-53. PubMed ID: 10078207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In silico screening of cancer-associated mutations in the HSA domain of BRG1 and its role in affecting the Arp-HSA sub-complex of SWI/SNF.
    S AS; Goutham R N A; Mohan S S
    Comput Biol Chem; 2018 Dec; 77():109-115. PubMed ID: 30286321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CK2-Dependent Phosphorylation of the Brg1 Chromatin Remodeling Enzyme Occurs during Mitosis.
    Padilla-Benavides T; Haokip DT; Yoon Y; Reyes-Gutierrez P; Rivera-Pérez JA; Imbalzano AN
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conventional and pioneer modes of glucocorticoid receptor interaction with enhancer chromatin in vivo.
    Johnson TA; Chereji RV; Stavreva DA; Morris SA; Hager GL; Clark DJ
    Nucleic Acids Res; 2018 Jan; 46(1):203-214. PubMed ID: 29126175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of chromatin remodelling revealed by the Snf2-nucleosome structure.
    Liu X; Li M; Xia X; Li X; Chen Z
    Nature; 2017 Apr; 544(7651):440-445. PubMed ID: 28424519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways.
    Alessio N; Squillaro T; Cipollaro M; Bagella L; Giordano A; Galderisi U
    Oncogene; 2010 Oct; 29(40):5452-63. PubMed ID: 20697355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myogenic microRNA expression requires ATP-dependent chromatin remodeling enzyme function.
    Mallappa C; Nasipak BT; Etheridge L; Androphy EJ; Jones SN; Sagerström CG; Ohkawa Y; Imbalzano AN
    Mol Cell Biol; 2010 Jul; 30(13):3176-86. PubMed ID: 20421421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation.
    Wu Q; Madany P; Dobson JR; Schnabl JM; Sharma S; Smith TC; van Wijnen AJ; Stein JL; Lian JB; Stein GS; Muthuswami R; Imbalzano AN; Nickerson JA
    Oncotarget; 2016 Jun; 7(25):38270-38281. PubMed ID: 27223259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms for nucleosome movement by ATP-dependent chromatin remodeling complexes.
    Saha A; Wittmeyer J; Cairns BR
    Results Probl Cell Differ; 2006; 41():127-48. PubMed ID: 16909894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression.
    Ooi L; Belyaev ND; Miyake K; Wood IC; Buckley NJ
    J Biol Chem; 2006 Dec; 281(51):38974-80. PubMed ID: 17023429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.